At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled / 40 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study Examining Changes in Nasal IL-1 During Acute Asthma Exacerbation in Adolescents
In Brief
An observational study for Asthma. Completed, enrolled 40 participants across 1 site.
Detailed Summary
To study the change from baseline in IL-1β (interleukin 1 beta) concentrations in the nasal airway during acute asthma exacerbation, specifically to measure the degree of change and identify the timing of peak IL-1β concentration. This information will allow the investigators to estimate effect size and guide decisions about the optimal timing of anakinra administration for the future study.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedFeb 2021
Enrollment StartJul 2021
Primary CompletionFeb 2024
TodayJul 2026
First PostedFeb 10, 2021
Enrollment StartJul 27, 2021
Primary CompletionFeb 8, 2024
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 5.4 years ago